TURKEY'S FIRST LOCAL PLASMA PRODUCTION FACILITY

Industry and Technology Minister Mustafa Varank stated that Turkey's first domestic plasma production facility has an investment value of 550 million Euros, and said, "With this facility, blood products that are produced only in 12 centers in the world, which unfortunately could not be produced in Turkey before, will be produced. That is, this factory. will be the 13th facility in this field in the world." said.

Minister Varank laid the foundation of the Plasma Products Production Facility, which was implemented in Silivri by the Maxicells company within the scope of the "Plasma Products Production Project", which aims to localize in medicine. Noting that the plasmas obtained from whole blood donations but not used and discarded will be evaluated in this factory, Varank said, "The contributions of this project to the health of our citizens far exceed its economic contribution. Hopefully, under the leadership of Maxicells, Turkey's first blood products biology laboratory will be established and drugs used in the treatment of important diseases will be developed here. " used the phrases.

550 MILLION EURO INVESTMENT

Noting that the openings of gigantic facilities have taken place one after the other recently, Varank said, "We are here with the groundbreaking ceremony of the plasma production facility with an investment value of 550 million Euros. This facility will have an indoor area of ​​approximately 66 thousand square meters and is being built on 172 acres of land.

13TH IN THE WORLD

Stating that the factory will be the 13th facility in the world in its field, Varank said, "With this facility, blood products that are produced only in 12 centers in the world, unfortunately, which could not be produced in Turkey before. "The most important issue in plasma products, blood supply, will be resolved as a result of the agreement with the Turkish Red Crescent." used the phrases.

WE ARE TAKING OUR STEPS WITH RESOLUTION

Pointing out that countries have made large-scale investments in the health sector, which has undergone a great transformation, Varank said, "The trade volume in pharmaceuticals and medical devices is over 2 trillion dollars. Especially with the pandemic, the economic and strategic importance of the sector was clearly seen. Today, wearable and mobile health applications are becoming more and more widespread. In this context, countries are making large-scale investments in the health sector, which has undergone a major transformation. We, as the Ministry of Industry and Technology, are decisively taking steps towards becoming a self-sufficient country under the leadership of the National Technology Move." he said.

A NEW ROADMAP IN SMART LIFE AND HEALTH

Stating that the new roadmap in the field of smart life and health will be announced at the beginning of next year, Varank said, "This year, we called for the development of many products, from hemoglobin to agglutinan serums, from polio vaccines to insulin-containing drugs, from ultrasound devices to computed tomography devices, with the Technology-Oriented Industry Move Program. With the move program that we will announce soon, we will add to our country's product range what we can produce locally and nationally from these products with high added value." said.

SUPPORT FOR PROJECTS

Stating that they support clusters of companies in the field of health all over the country, Varank said, "We provide serious support to technology centers that provide thematic incubation services for health technologies such as biotechnology, medicine, medical device, medical and genetics, through KOSGEB. Pharmaceuticals, health and medical sectors. The exemptions and tax advantages we provide to our R&D centers have now exceeded 600 million TL. In addition, we will continue to support R&D projects in the health, medical device and pharmaceutical sectors through TÜBİTAK." he said.

R&D EXPENDITURES

Noting that the ratio of R&D expenditures to national income increased to 1.09 percent in 2020, Varank said, "This rate was only 5 per thousand in 2002. The most important thing is that this R&D expenditure and investments are increasing under the leadership of the private sector. Our private sector realized 65 percent of the financing and 57 percent of the financing." said.

INVESTMENT INVESTMENT

Inviting both Turkish and global companies to invest in Turkey, Varank said, "Our country is a profitable and safe harbor for your investments with its competitive business environment, attractive incentives, strong financial system and macroeconomic structure created under the leadership of our President. Let's evaluate it together, let's win together." used the phrases.

Emphasizing the importance of the investment, Istanbul Governor Ali Yerlikaya said, "We are really witnessing a historical investment not only for our Silivri, but also for our Istanbul, but as a whole country." said.

Maxicells Chairman of the Board Dr. Hakan Kazancı continued his work within the scope of the Plasma Products Procurement Project Agreement signed between SGK and Maxicells in August 2018.

He stated that this giant and strategic project they started continued with the same determination and belief as the first day.

In addition to Minister Varank, Deputy Minister of Industry and Technology Hasan Büyükdede, Deputy Minister of Labor and Social Security Dr. Adnan Ertem, AK Party Istanbul Deputy Tülay Kaynarca, Silivri Mayor Volkan Yılmaz, KOSGEB President Hasan Basri Kurt and many guests attended.